Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04014400 · ClinicalTrials.gov registry record · NA
Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites
A NA study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04014400 is a NA study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 10 participants.
The verdict
NCT04014400, a NA study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The investigators aim to study whether Suprathel, a synthetic temporary skin substitute developed by PolyMedics Innovations GmBH aids in the management of patient pain and wound healing when compared to the current standard dressing used of a primary Xeroform dressing.
Interventions
- OTHER Suprathel or Xeroform donor site application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-07-07 |
| Est. Completion | 2020-07-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04014400
The ClinicalTrials.gov registry entry for NCT04014400 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Suprathel or Xeroform donor site application is the first listed.
NCT04014400 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04014400 about?
NCT04014400 is a clinical study titled "Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites". The investigators aim to study whether Suprathel, a synthetic temporary skin substitute developed by PolyMedics Innovations GmBH aids in the management of patient pain and wound healing when compared to the current standard dressing used of a primary Xeroform dressing.
What is the current status of trial NCT04014400?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2019-07-07. Estimated completion is 2020-07-23.
What interventions are being tested in trial NCT04014400?
The interventions under investigation include: Suprathel or Xeroform donor site application (OTHER).
Who is sponsoring clinical trial NCT04014400?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.